Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Multiple sclerosis-like neurological manifestations in a coeliac patient: nothing is as it seems.
Dual Targeting of the Chemokine Receptors CXCR4 and ACKR3 with Novel Engineered Chemokines.
The Fc Receptor-Like 3 Polymorphisms (rs7528684, rs945635, rs3761959 and rs2282284) and The Risk of Neuromyelitis Optica in A Chinese Population.
Wavelet-Based Scalar-on-Function Finite Mixture Regression Models.
Estrogen receptor β ligand therapy activates PI3K/Akt/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis.
What is the relevance of quality of life assessment for patients with attention impairment?
Acute disseminated encephalomyelitis.
Enrichment for Northern European-derived multiple sclerosis risk alleles in Sardinia.
Time-Lapse Imaging of Glial-Axonal Interactions.
Childhood obesity is a risk factor for multiple sclerosis.
Prognostic Indicators of Acute Transverse Myelitis in 39 Children.
Astrogliosis as a therapeutic target for neurodegenerative diseases.
Deficient phosphorylation of stat1 in leukocytes identifies neutralizing antibodies in multiple sclerosis patients treated with interferon-Beta.
An adverse lipid profile is associated with disability and progression in disability, in people with MS.
Fast facts: multiple sclerosis.
Frontiers in therapeutic development of allopregnanolone for Alzheimer's disease and other neurological disorders.
Multiple Sclerosis (MS) as a demyelinating disease: a review on neurosurgical approaches.
Performance on Paced Auditory Serial Addition Test and cerebral blood flow in multiple sclerosis.
Inhibition of Myeloperoxidase at the Peak of Experimental Autoimmune Encephalomyelitis Restores Blood-Brain-Barrier Integrity and Ameliorates Disease Severity.
Reduced Myelin Water in the White Matter Tracts of Patients with Niemann-Pick Disease Type C.
Functionally Relevant White Matter Degradation in Multiple Sclerosis: A Tract-based Spatial Meta-Analysis.
Multiple sclerosis-like lesions and type I interferon signature in a patient with RVCL.
Comparison of regular aerobic and yoga on the quality of life in patients with multiple sclerosis.
Abnormally high levels of anti-collagen type IV IgG antibodies in the serum of patients with a clinically isolated syndrome correlate with an increased risk of conversion to MS.
S-Allylmercapto-N-acetylcysteine (ASSNAC) protects cultured nerve cells from oxidative stress and attenuates experimental autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
399
400
401
402
403
404
405
406
407
…
next ›
last »